Pea Coat Buttons Male Or Female

The "dealer of opinion," those who sell their power influence, not recruited as among medical experts. Journalists also have a lot of ethical tightrope, this time in journalism.

With Mediator case, the public taking affine understanding of the infiltration of medical information by financial interests, including pharmaceuticals. However, a few months ago, the pathetic management of the pandemic H1N1 showed that actually pulled the strings in the French public health as well as international.

This situation is now commonplace. Until recently, the President of the powerful and wealthy French Society of Cardiology stated in the World " I'm not shocked that there is infiltration of Learned Societies by laboratories ". Unbelievable, huh?

When we pass the bounds, there is no more limits we said Alfred Jarry.

But some journalists play an important role in the disinformation oriented.

Helena Cardin health specialist on France Inter, this is a caricature of deviance. Its showpiece was a The phone rings on hormones to treat menopause. It was this treatment which helps rehabilitate yet breast cancer. She asked why the "Notables menopause [1 ] with whom she wrote a book on the subject, to extol the benefits.

via atoute.org

In practice, dealers opinion would be nothing their counterparts without "journalists." Shame on them!

Posted via email from hypha's posterous

Masterbation With A Freind

A U.S. study reveals a key to Alzheimer's disease presenting in Because the theory of overproduction of beta-amyloid plaque in the brain. Researchers directed by Dr. Randall Beteman of Washington University in St. Louis have shown that people with Alzheimer's disease can not eliminate the beta-amyloid plaque while it is produced in the same amount healthy people the same age. People with Alzheimer's disease are between 100 to 1000 times the amount of beta-amyloid in the brain than healthy people.

The researchers compared 12 people with Alzheimer's disease and 12 healthy people. The production of beta-amyloid plaque was identical in both groups but the researchers found a 30% decrease in the ability to clear beta-amyloid plaque in people with Alzheimer's disease.

A 30% decrease in the ability to clear beta-amyloid plaque means that the disease takes 10 years before patients show signs of mental impairment.

This discovery is key to the development of new treatments according to the researchers who published their findings in the renowned journal Science . By A Bless according to Science and analysis Pharmactua

via pharmactua.com

Posted via email from hypha's posterous

Eat Corn Diverticulitus

The occurrence of metastasis is a frequent event in the natural history of colonic cancer. In 20 to 30% of cases, metastases are synchronous with the discovery of the primary tumor. Furthermore, 50% of patients operated on for colonic adenocarcinoma with lymph node metastases during their evolution. Highlighting metastases in the development of colon cancer leads to systematically raise the possibility of surgical resection. In case of non-resectable metastases, the proposed treatment of chemotherapy is justified if the condition is retained. This chemotherapy was the main objective to increase the life and especially life without symptoms. The data published in a recent meta-analysis shows that the achievement of chemotherapy increases by 50% survival at 1 year without deterioration of quality of life [1]. A second goal of treatment is to enable resection of metastases. This is rare in multicenter studies [2]. The goal of treatment is usually palliative and should be clearly explained to the patient. This objective is to palliative corollary notions of chronicity (of the disease and treatment) and very high probability of death from disease progression.

The development of treatment regimens in response to a specific methodology. Drugs or drug combinations are, firstly, as assessed by clinical phase II. In these studies, the toxicity is the primary endpoint, efficiency is a secondary criterion, usually summed up by the response rate (WHO criteria). The response rate is an intermediate criterion, reproducible, confirming the effectiveness of chemotherapy on tumor disease but it can not replace the main goal of treatment is life. The Phase II study is a step of selecting treatment regimens. In a second step, the patterns of the most promising phase II are compared with the reference scheme to try to show a survival advantage. These randomized prospective studies (Phase III) or their meta-analysis have the primary endpoint of the life and the secondary criteria of life without symptoms or progression-free life. For methodological reasons, only phase III trials and meta-analysis allows the rigorous comparison of the results of survival data, toxicity and quality of life.

The recent history of chemotherapy for colon cancer has experienced two major periods. The first of 1959 to early 90's considered the only drug considered potentially effective, 5 fluorouracil (5FU) and its various methods of administration and Biomodule. This period led to the development of several schemes of "reference" in different countries and continents. The second period began with the development of new drugs (irinotecan, oxaliplatin, raltitrexed) and caused a change in the therapeutic management with the demonstration of the effectiveness of second-line treatment [3].

In the first part, tells us, using the methodological tools of evidence-based medicine (evidence-based medicine, EBM) presented in the introduction, the evolution of treatment regimens for 10 years. In

a second part, we discuss the problems of choice between different patterns.

via fmcgastro.org

Posted via email from hypha's posterous